API: Active Pharmaceutical Ingredients

The API market in the US is as expected growing at a CAGR of 7% over the period 2014-2019. The market research and analysis estimates that in terms of geographic regions, the Americas will be the major revenue contributor to the active pharmaceutical ingredients market throughout the next four years. The increasing demand for generic drugs from countries such as the US, the growth in aging population, and the presence of an organized R&D structure for drug development are some of the major factors that will drive the growth of the market in this region.  The key vendors in this sector are Abbott Laboratories, Aurobindo Pharma, Mylan and Teva Pharmaceutical Industries. 

  • API outsourcings
  • US API market
  • European API market
  • Asian API market
  • Antibody Drug Conjugate (ADCs)
  • Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
  • Biological API market

Related Conference of API: Active Pharmaceutical Ingredients

November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

API: Active Pharmaceutical Ingredients Conference Speakers

Recommended Sessions

Related Journals

Are you interested in